Cadmium carcinogenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 107-120

  Waalkes, Michael P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cadmium; Carcinogenesis; Humans; Mechanisms; Rodents

Indexed keywords

CADMIUM;

ADRENAL CORTEX CARCINOMA; CARCINOGENESIS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HEMATOPOIETIC SYSTEM; HUMAN; KIDNEY CARCINOMA; LIVER CARCINOGENESIS; LUNG ADENOCARCINOMA; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; STOMACH CARCINOGENESIS;

ANIMALIA; RODENTIA;

EID: 0345708255     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.07.011     Document Type: Review

References (77)

1. P.L. Goering, M.P. Waalkes, C.D. Klaassen, Toxicology of Cadmium, in: R.A. Goyer, M.G. Cherian (Eds.), Handbook of Experimental Pharmacology: Toxicology of Metals, Biochemical Effects, vol. 115, Springer-Verlag, New York, 1994, pp. 189-214.
2. Satarug S., Baker J.R., Urbenjapol S., Haswell-Elkins M., Reilly P.E.B., Williams D.J., Moore M.R. A global presepective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol. Lett. 137:2003;65-83.
3. Klaassen C.D., Liu J., Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu. Rev. Pharmacol. Toxicol. 39:1999;267-294.
4. Waalkes M.P. Cadmium Carcinogenesis in review. J. Inorg. Biochem. 79:2000;241-244.
5. International Agency for Research on Cancer Monographs, Beryllium, Cadmium, Mercury and Exposures in the Glass Industry, vol. 58, IARC, Lyon, 1993, pp. 119-238.
6. National Toxicology Program, Tenth Report on Carcinogens, Department of Health and Human Services, Research Triangle Park, NC, 2000, pp. III-42-III-44.
7. Pesch B., Haerting J., Ranft U., Klimpel A., Oelschlagel B., Schill W. MURC Study Group. Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. Int. J. Epidemiol. 29:2000;1014-1024.
8. Hu J., Mao Y., White K. Canadian Cancer Registries Epidemiology Research Group. Renal cell carcinoma and occupational exposure in Canada. Occup. Med. 52:2002;157-164.
9. M.P. Waalkes, R.R. Misra, Cadmium carcinogenicity and genotoxicity, in: L. Chang (Ed.), Toxicology of Metals, CRC Press, Boca Raton, FL, 1996, pp. 231-244.
10. Schwartz G.G., Reis I.M. Is cadmium a cause of human pancreatic cancer. Cancer Epideniol. Biomarkers Prev. 9:2000;139-145.
11. Waalkes M.P., Anver M., Diwan B. Carcinogenic effects of cadmium in the Noble (NBL/Cr) Rat: induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate. Toxicol. Sci. 52:1999;154-161.
12. Waalkes M.P., Anver M., Diwan B. Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) Rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate and testes. J. Toxicol. Environ. Health. 58:1999;199-214.
13. Leazer T.M., Liu Y., Klaassen C.D. Cadmium absorption and its relationship to divalent metal transporter-1 in the pregnant rat. Toxicol. Appl. Pharmacol. 185:2002;18-24.
14. Hamadek H.K., Bushel P.R., Jayadev S., DiSorbo O., Bennett L., Li L., Tennant R., Stoll R., Barrett J.C., Paules R.S., Blanchard K., Afshari C.A. Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. 67:2002;232-240.
15. Achanzar W.E., Diwan B.A., Quader S.T., Webber M.M., Waalkes M.P. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res. 61:2001;455-458.
16. Nakamura K., Yasunaga Y., Ko D., Xu L.L., Moul J.W., Peehl D.M., Srivastava S., Rhim J.S. Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int. J. Oncol. 20:2002;543-547.
17. Haddow A., Dukes C.E., Mitchley B.C.V. Carcinogenicity of iron preparations and metal-carbohydrate complexes. Ann. Rep. Br. Empire Cancer Campaign. 37:1961;74.
18. Takenaka S., Oldiges H., König H., Hochrainer D., Oberdörster G. Carcinogenicity of cadmium chloride aerosols in W rats. J. Natl. Cancer Inst. 70:1983;367.
19. Liu J., Corton C., Dix D.J., Liu Y., Waalkes M.P., Klaassen C.D. Genetic background and not metallothionein-null phenotype dictates sensitivity to cadmium-induced testicular injury in mice. Toxicol. Appl. Pharmacol. 176:2001;1-9.
20. Cook J.C., Klinefelter G.R., Hardisty J.F., Sharpe R.M., Foster P.M. Rodent Leydig cell tumorigenesis: review of the physiology, pathology, mechanisms, and relevance to humans. Crit. Rev. Toxicol. 29:1999;169-261.
21. Waalkes M.P., Rehm S., Devor D.E. The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: loss of testicular response. Toxicol. Appl. Pharmacol. 142:1997;40-46.
22. Rehm S., Waalkes M.P. Cadmium-induced ovarian toxicity in hamsters, mice, and rats. Fundam. Appl. Toxicol. 10:1988;635-647.
23. Waalkes M.P., Rehm S. Lack of carcinogenicity of cadmium chloride in female Syrian hamsters. Toxicology. 126:1998;173-178.
24. Coffey D.S., Isaacs J.T. Control of prostate growth. Urology. 3:1981;17-24.
25. Nobel R.L. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res. 37:1977;1929-1933.
26. Shirai T., Iwasaki S., Masui T., Mori T., Kato T., Ito N. Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2′-dimethyl-4-aminobiphenyl. Jpn. J. Cancer Res. 84:1993;1023-1030.
27. Terracio L., Nachtigal M. Oncogenicity of rat prostate cells transformed in vitro with cadmium chloride. Arch. Toxicol. 61:1988;450-456.
28. M.P. Waalkes, Metal carcinogenesis, in: B. Sarkar (Ed.), Handbook of Heavy Metals in the Environment, Marcel Dekker, New York, 2002, pp. 121-146.
29. Waalkes M.P., Rehm S., Cherian M.G. Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. Toxicol. Sci. 54:2000;110-120.
30. Waalkes M.P., Rehm S. Chronic toxic and carcinogenic effects of cadmium chloride in male DBA/2NCr and NFS/NCr mice: strain-dependent association with tumors of the hematopoietic system, injection site, liver, and lung. Fundam. Appl. Toxicol. 23:1994;21-31.
31. Wade G.G., Mandel R., Ryser H.J.-P. Marked synergism of dimethylnitrosamine carcinogenesis in rats exposed to cadmium. Cancer Res. 47:1987;6606-6613.
32. Waalkes M.P., Diwan B.A., Bare R.M., Ward J.M., Weghorst C., Rice J.M. Anticarcinogenic effects of cadmium in B6C3F1 mouse liver and lung. Toxicol. Appl. Pharmacol. 110:1991;327-335.
33. Waalkes M.P., Diwan B.A., Weghorst C.M., Ward J.M., Rice J.M., Cherian M.G., Goyer R.A. Further evidence of tumor suppressive effects of cadmium in the B6C3F1 mouse liver and lung: late stage vulnerability of tumors to cadmium and the role of metallothionein. J. Pharmacol. Exp. Therap. 266:1993;1656-1663.
34. Kurokawa Y., Matsushima M., Imazawa T., Takamura T., Takahashi M., Hayashi Y. Promoting effect of metal compounds on liver, stomach, kidney, pancreas and skin carcinogenesis. J. Am. Coll. Toxicol. 8:1989;1235-1239.
35. Gunn S.A., Gould T.C., Anderson W.A.D. Effect of zinc on cancerogenesis by cadmium. Proc. Soc. Exp. Biol. Med. 115:1964;653-657.
36. McKenna I.M., Waalkes M.P., Chen L.C., Gordon T. Comparison of inflammatory lung responses in Wistar rats and C57 and DBA mice following acute exposure to cadmium oxide fumes. Toxicol. Appl. Pharmacol. 146:1997;196-206.
37. McKenna I.M., Gordon T., Chen L.C., Anver M.R., Waalkes M.P. Expression of metallothionein protein in the lungs of Wistar rats and C57 and DBA mice exposed to cadmium oxide fumes. Toxicol. Appl. Pharmacol. 153:1998;169-178.
38. Waalkes M.P., Poirier L.A. In vitro cadmium-DNA interactions: cooperativity of cadmium binding and competitive antagonism by calcium. Toxicol. Appl. Pharmacol. 75:1984;539-546.
39. Kasprzak K.S. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic. Biol. Med. 32:2002;958-967.
40. Shimizu M., Hochadel J.F., Abshire M.K., Waalkes M.P. Effects of glutathione depletion on cadmium-induced metallothionein synthesis, cytotoxicity, and proto-oncogene expression in cultured rat myoblasts. J. Toxicol. Environ. Health. 51:1997;609-621.
41. Hart B.A., Lee C.H., Shukla G.S., Shukla A., Osier M., Eneman J.D., Chiu J.-F. Characterization of cadmium-induced apoptosis in rat lung epithelial cells: evidence for the participation of oxidant stress. Toxicology. 133:1999;43-58.
42. Hart B.A., Potts R.J., Watkin R.D. Cadmium adaption in the lung - a double-edged sword? Toxicology. 160:2001;65-70.
43. Misra R.R., Smith G.T., Waalkes M.P. Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. Toxicology. 126:1998;103-114.
44. Misra R.R., Page J.E., Smith G.T., Waalkes M.P., Dipple A. Effect of cadmium exposure on background and anti 5-methylchrysene 1,2-dihydrodiol 3,4-epoxide-induced mutagenesis in the supF gene of pS189 in human Ad293 cells. Chem. Res. Toxicol. 11:1998;211-216.
45. Gille J.J.P., van Berkel C.G.M., Joenje H. Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis. 15:1994;2695-2699.
46. Reid T.M., Feig D.I., Loeb L.A. Mutagenesis by metal-induced oxygen radicals. Environ. Health Perspect. 102(Suppl. 3):1994;57-61.
47. Yang J.-L., Chao J.-I., Lin J.-G. Reactive oxygen species may participate in the mutagenicity and mutational spectrum of cadmium in Chinese hamster ovary-K1 cells. Chem. Res. Toxicol. 9:1996;1360-1367.
48. Hartwig A. Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol. Lett. 102-103:1998;235-239.
49. Beyersman D., Hechtenberg S. Cadmium, gene regulation, and cellular signaling in mammalian cells. Toxicol. Appl. Pharmacol. 144:1997;247-261.
50. Verougstraete V., Lison D., Holtz P. A systematic review of cytogenetic studies conducted in human populations exposed to cadmium compounds. Mutat. Res. 511:2002;15-43.
51. Watson R.E., Goodman J.I. Epigenetics and DNA methylation come of age in toxicology. Toxicol. Sci. 67:2002;11-16.
52. Goodman J.I., Watson R.E. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 42:2002;501-525.
53. Beyersman D. Effects of carcinogenic metals on gene expression. Toxicol. Lett. 127:2002;63-68.
54. Abshire M.K., Buzard G.S., Shiraishi N., Waalkes M.P. Induction of proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene. J. Toxicol. Environ. Health. 48:1996;359-377.
55. Zheng H., Liu J., Choo K.H., Michalska A.E., Klaassen C.D. Metallothionein-l and ll knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol. Appl. Pharmacol. 136:1996;229-235.
56. Achanzar W.E., Achanzar K.B., Lewis J.G., Webber M.M., Waalkes M.P. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol. Appl. Pharmacol. 164:2000;291-300.
57. Joseph P., Muchnok T.K., Klishis M.L., Roberst J.R., Antonini J.M., Whong W.Z., Ong T. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species. Toxicol. Sci. 61:2001;295-303.
58. Hechtenberg S., Schafer T., Benters J., Beyersman D. Effects of cadmium on cellular proto-oncogene expression. Ann. Clin. Lab. Sci. 26:1996;512-521.
59. Spruill M.D., Song B., Whong W.-Z., Ong T. Proto-oncogene amplification and overexpression in cadmium-induced cell transformation. J. Toxicol. Environm. Health. 65:2002;2131-2144.
60. Joseph P., Lei Y.X., Whong W.Z., Ong T. Oncogenic potential of mouse trabslation elongation factor-1 delta, a novel cadmium-responsive proto-oncogene. J. Biol. Chem. 277:2002;6131-6136.
61. Joseph P., Lei Y.X., Whong W.-Z., Ong T. Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res. 62:2002;703-707.
62. Huang C., Zhang Q., Li J., Shi X., Castrinova V., Ju G., Coata M., Dong Z. Involvement of Rrks activation in cadmium-induced AP-1 transactivation in vitro and in vivo. Mol. Cell. Biochem. 222:2001;141-147.
63. Keshava N., Zhou G., Hubbs A.F., Ensell M.X., Ong T. Transforming and carcinogenic potential of cadmium chloride in BALB/c-3T3 cells. Mutat. Res. 448:2000;23-28.
64. M. Takiguchi, W.E. Achanzar, W. Qu, G. Li, M.P. Waalkes, Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation, Exp. Cell Res., in press.
65. Poirier L.A., Vlasova T.I. The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ. Health Perspect. 110(Suppl. 5):2002;793-795.
66. Jeon S.H., Cho M.H., Cho J.H. Effects of cadmium on gap junctional intercellular communications in WB-F344 rat liver epithelial cells. Hum. Exp. Toxicol. 20:2001;577-583.
67. Pearson C.A., Prozialeck W.C. E-Cadherin, beta-catenin and cadmium carcinogenesis. Med. Hypotheses. 56:2001;573-581.
68. Waalkes M.P., Fox D.A., States J.C., Patierno S.R., McCabe M.J. Jr. Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicol. Sci. 56:2000;255-261.
69. Shimada H., Shiao Y.-H., Shibata M.A., Waalkes M.P. Cadmium suppresses apoptosis induced by chromium. J. Toxicol. Environ. Health. 54:1998;159-168.
70. Yuan C., Kadiiska M.B., Achanzar W.E., Mason R., Waalkes M.P. Studies on the mechanisms of cadmium-induced blockage of apoptosis: possible role of caspase-3 inhibition. Toxicol. Appl. Pharmacol. 164:2000;321-329.
71. Achanzar W.E., Liu J., Webber M.M., Waalkes M.P. Acquired apoptotic resistance in human prostate epithelial cells malignantly transformed by cadmium. Prostate. 52:2002;236-244.
72. Martin J.J., Martin R., Codesal J., Fraile B., Paniagua R., Santamaria L. Cadmium chloride-induced dsyplastic changes in the ventral prostate: an immunohistochemical and quantitative study. Prostate. 46:2001;11-20.
73. Meplan C., Mann K., Hainaut P. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured calls. J. Biol. Chem. 274:1999;31663-31670.
74. Fang M.Z., Mar W., Cho M.H. Cadmium affects genes involved in growth regulation during two-stage transformation of BALB/3T3 cells. Toxicology. 177:2002;253-265.
75. Abshire M.K., Devor D.E., Diwan B.A., Shaughnessy J.D., Waalkes M.P. In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo. Carcinogenesis. 17:1996;1349-1356.
76. Haga A., Nagase H., Kito H., Sato T. Invasive properties of cadmium-resistant human fibrosarcoma HT-1080 cells. Cancer Biochem. Biophys. 15:1997;275-284.
77. Haga A., Nagase H., Kito H., Sato T. Enhanced invasiveness of tumour cells after host exposure to heavy metals. Eur. J. Cancer. 32A:1996;2342-2347.